Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT01258608 · COMPLETED
Trial details
- NCT number
- NCT01258608
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-08
- Primary completion
- 2013-05-31
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.